ZYNEX INC (ZYXI) Stock Price, Quote, News and Overview
NASDAQ:ZYXI - Nasdaq - US98986M1036 - Common Stock - Currency: USD
ZYXI Quote, Performance and Key Statistics
2.47
+0.11 (+4.66%)
The current stock price of ZYXI is 2.47 USD. In the past month the price increased by 9.29%. In the past year, price decreased by -76.52%.
ZYXI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.28 | 234.48B | ||
| ISRG | INTUITIVE SURGICAL INC | 72.93 | 199.70B | ||
| BSX | BOSTON SCIENTIFIC CORP | 39.46 | 157.58B | ||
| SYK | STRYKER CORP | 31.09 | 148.69B | ||
| MDT | MEDTRONIC PLC | 16.17 | 110.77B | ||
| BDX | BECTON DICKINSON AND CO | 12.54 | 50.73B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.93 | 45.76B | ||
| IDXX | IDEXX LABORATORIES INC | 45.36 | 41.91B | ||
| RMD | RESMED INC | 27.33 | 36.38B | ||
| DXCM | DEXCOM INC | 52.93 | 34.25B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.62 | 32.90B | ||
| STE | STERIS PLC | 26.82 | 24.61B |
Related stock screener links
About ZYXI
Company Profile
Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. The company is headquartered in Englewood, Colorado and currently employs 1,000 full-time employees. The company went IPO on 2002-11-27. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.
Company Info
ZYNEX INC
9655 Maroon Circle
Englewood COLORADO 80112 US
CEO: Thomas Sandgaard
Employees: 1000
Phone: 18004956670
ZYNEX INC / ZYXI FAQ
What is the stock price of ZYNEX INC today?
The current stock price of ZYXI is 2.47 USD. The price increased by 4.66% in the last trading session.
What is the ticker symbol for ZYNEX INC stock?
The exchange symbol of ZYNEX INC is ZYXI and it is listed on the Nasdaq exchange.
On which exchange is ZYXI stock listed?
ZYXI stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ZYNEX INC stock?
9 analysts have analysed ZYXI and the average price target is 6.12 USD. This implies a price increase of 147.77% is expected in the next year compared to the current price of 2.47. Check the ZYNEX INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ZYNEX INC worth?
ZYNEX INC (ZYXI) has a market capitalization of 74.69M USD. This makes ZYXI a Micro Cap stock.
How many employees does ZYNEX INC have?
ZYNEX INC (ZYXI) currently has 1000 employees.
What are the support and resistance levels for ZYNEX INC (ZYXI) stock?
ZYNEX INC (ZYXI) has a resistance level at 2.49. Check the full technical report for a detailed analysis of ZYXI support and resistance levels.
Is ZYNEX INC (ZYXI) expected to grow?
The Revenue of ZYNEX INC (ZYXI) is expected to decline by -41.75% in the next year. Check the estimates tab for more information on the ZYXI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ZYNEX INC (ZYXI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ZYXI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ZYXI, evaluating the profitability, health, valuation and growth aspects
- ZYNEX INC (ZYXI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ZYNEX INC (ZYXI) Sales and EPS estimates to see what analysts future expectations are.
- ZYNEX INC (ZYXI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ZYNEX INC (ZYXI) Insider and Institutional Ownership to learn about the owners and their transactions.
- ZYNEX INC (ZYXI) Stock Chart to make your own analysis
- ZYNEX INC (ZYXI) Latest news and press-releases to stay up to date.
Does ZYNEX INC (ZYXI) stock pay dividends?
ZYXI does not pay a dividend.
When does ZYNEX INC (ZYXI) report earnings?
ZYNEX INC (ZYXI) will report earnings on 2025-07-23, after the market close.
What is the Price/Earnings (PE) ratio of ZYNEX INC (ZYXI)?
ZYNEX INC (ZYXI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.24).
What is the Short Interest ratio of ZYNEX INC (ZYXI) stock?
The outstanding short interest for ZYNEX INC (ZYXI) is 24.17% of its float. Check the ownership tab for more information on the ZYXI short interest.
ZYXI Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ZYXI. When comparing the yearly performance of all stocks, ZYXI is a bad performer in the overall market: 98.42% of all stocks are doing better.
ZYXI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ZYXI. ZYXI has an average financial health and profitability rating.
ZYXI Financial Highlights
Over the last trailing twelve months ZYXI reported a non-GAAP Earnings per Share(EPS) of -0.24. The EPS decreased by -160% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -7.01% | ||
| ROE | -35.68% | ||
| Debt/Equity | 2.87 |
ZYXI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 78% to ZYXI. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of -987.77% and a revenue growth -41.75% for ZYXI